Australian New Zealand Clinical Trials Registry

The Australian Particle Therapy Clinical Quality Registry – ASPIRE  is registered with the Australian New Zealand Clinical Trials Registry (ANZCTR).  The ANZCTR is recognised as an international committee of Medical Journal Editors acceptable registry and a Primary Registry in the World Health Organisation (WHO) registry network.

 

Additional information on the Australian Particle Therapy Clinical Quality Registry – ASPIRE can be found on the following link➡️  ANZCTR – Registration

 

 

 

 

TROG Cancer Research

Trans-Tasman Radiation Oncology Group – TROG Cancer Research, is dedicated to improving the way radiation therapy is delivered to cancer patients with ongoing scientific research, clinical trials, and cutting-edge technology.

 

TROG Cancer Research are proud collaborators of the Australian Bragg Centre for Cancer Research and have endorsed the Australian Particle Therapy Clinical Quality Registry – ASPIRE.

 

Learn more about the great work being done by TROG Cancer Research on their website ➡️  https://trog.com.au/